Daniel S Orlovich, MD, PHARM D
Pain Medicine · Van Nuys
- Medicare standing
- 1 flag on the record
- Listed below.
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
On the public record
- Medicare does not list them as allowed to order and refer
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Orlovich’s office at (818) 901-6600 to ask if they take your plan before you enroll.
California Medical Board record
Licence A150520 · Current
Licensed to practise in California · since 2017 · expires 2027-05-31 · University of California, Irvine College of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$116,915
Medicare paid this office $116,915 for 397 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 318 | $46,757 | $96 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 65 | $7,323 | $106 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | 28 | $6,106 | $218 |
| New patient visit (45+ min) | 46 | $5,295 | $115 |
| Short return visit (20+ min) | 58 | $4,998 | $77 |
See all 19 services
| Return visit (30+ min) | 318 | $46,757 | $96 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 65 | $7,323 | $106 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | 28 | $6,106 | $218 |
| New patient visit (45+ min) | 46 | $5,295 | $115 |
| Short return visit (20+ min) | 58 | $4,998 | $77 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 32 | $4,598 | $96 |
| Heat destruction of intraosseous basivertebral nerve in bones of spine in lower back, first two bones | 13 | $4,199 | $323 |
| Injection of upper or middle spine facet joint using imaging guidance, single level | 20 | $3,002 | $100 |
| Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | 32 | $2,919 | $73 |
| Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint | 13 | $2,454 | $189 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 29 | $2,428 | $54 |
| Injection of substance into lower spine canal using imaging guidance | 25 | $2,232 | $77 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 43 | $1,886 | $42 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | 28 | $1,817 | $65 |
| Injection of upper or middle spine facet joint using imaging guidance, second level | 20 | $1,593 | $55 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 109 | $1,497 | $12 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 12 | $1,037 | $69 |
| X-ray of lower and sacral spine, minimum of 4 views | 27 | $957 | $35 |
| Destruction of upper or middle spinal facet joint nerves using imaging guidance, each additional facet joint | 12 | $782 | $65 |
Procedures year by year
| Procedure | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Injection of lower or sacral spine facet joint using imaging guidance, single level | – | – | 153 | 125 | 48 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | – | 16 | 100 | 126 | 69 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | – | – | 143 | 118 | 45 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | – | 14 | 80 | 85 | 45 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | – | – | 56 | 82 | 28 |
| Injection of substance into lower spine canal using imaging guidance | – | – | 65 | 69 | 29 |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
397 Original Medicare patients in 2024. Average age 75 · Under 65 5% · 85 and older 16% · Women 62% · Also on Medicaid 11% · Health risk score 1.29. At or below the middle of the specialty; the typical pain management clinician is at 1.38.
Conditions among them: High blood pressure 75% · Coronary heart disease 44% · Diabetes 30% · Depression 28% · Chronic kidney disease 24% · Cancer 20% · Atrial fibrillation 19% · COPD 17% · Heart failure 15% · Stroke 11% · Dementia 8%.
The office billed $1,324,421, Medicare allowed $160,069 and paid $116,915; for 1,335 services of 54 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 397 | 1,335 | 75 | 1.29 | $1,324,421 | $116,915 |
| 2023 | 666 | 2,639 | 75 | 1.25 | $2,924,204 | $268,113 |
| 2022 | 508 | 2,402 | 74 | 1.22 | $2,439,049 | $230,299 |
| 2021 | 152 | 339 | 72 | 1.90 | $285,878 | $33,471 |
| 2020 | 44 | 48 | 69 | 2.79 | $78,704 | $10,514 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 23 services
| Return visit (30+ min) | 544 | $118,083 | $106 |
| New patient visit (45+ min) | 149 | $19,839 | $133 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | 67 | $15,537 | $189 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 109 | $13,368 | $106 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 78 | $12,689 | $102 |
| Short return visit (20+ min) | 134 | $11,843 | $71 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 74 | $6,704 | $57 |
| Injection of upper or middle spine facet joint using imaging guidance, single level | 34 | $5,893 | $116 |
| Injection of substance into lower spine canal using imaging guidance | 62 | $5,726 | $83 |
| Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | 53 | $4,916 | $76 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 42 | $4,199 | $84 |
| Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint | 19 | $4,047 | $193 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | 57 | $4,047 | $57 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 73 | $3,793 | $45 |
| Destruction of nerves supplying joint between spine and pelvis using imaging guidance | 20 | $3,460 | $173 |
| Injection of upper or middle spine facet joint using imaging guidance, second level | 34 | $3,126 | $64 |
| Injection of substance into middle or upper spine canal using imaging guidance | 23 | $2,149 | $90 |
| Destruction of nerve branches of knee using imaging guidance | 13 | $1,730 | $124 |
| Destruction of upper or middle spinal facet joint nerves using imaging guidance, each additional facet joint | 18 | $1,389 | $66 |
| Injection of anesthetic agent and/or steroid into knee nerve branch using imaging guidance | 18 | $1,203 | $67 |
| Aspiration and/or injection of fluid from large joint | 18 | $1,168 | $58 |
| X-ray of lower and sacral spine, minimum of 4 views | 13 | $622 | $48 |
| Injection of anesthetic agent and/or steroid into other nerve or branch | 15 | $423 | $26 |
2022: 25 services
| Return visit (30+ min) | 399 | $85,444 | $108 |
| Short return visit (20+ min) | 176 | $21,790 | $78 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 88 | $16,080 | $105 |
| New patient visit (45+ min) | 106 | $13,450 | $127 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | 52 | $12,691 | $227 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 87 | $10,102 | $101 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 81 | $8,549 | $60 |
| Injection of substance into lower spine canal using imaging guidance | 50 | $5,403 | $83 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 35 | $4,128 | $84 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | 51 | $3,688 | $68 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 69 | $3,496 | $44 |
| Telephone medical discussion with physician, 11-20 minutes | 43 | $3,003 | $56 |
| Injection of upper or middle spine facet joint using imaging guidance, single level | 22 | $2,963 | $99 |
| New patient visit (60+ min) | 17 | $2,747 | $162 |
| Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint | 14 | $2,610 | $163 |
| Long return visit (40+ min) | 22 | $2,511 | $114 |
| Injection of substance into middle or upper spine canal using imaging guidance | 22 | $2,451 | $88 |
| Destruction of nerve branches of knee using imaging guidance | 15 | $2,369 | $125 |
| Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | 23 | $2,197 | $81 |
| Injection of anesthetic agent and/or steroid into knee nerve branch using imaging guidance | 24 | $1,821 | $70 |
| Injection of upper or middle spine facet joint using imaging guidance, second level | 20 | $1,496 | $55 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 42 | $1,345 | $26 |
| Aspiration and/or injection of fluid from large joint | 19 | $1,105 | $53 |
| Telephone medical discussion with physician, 21-30 minutes | 12 | $1,092 | $73 |
| Destruction of upper or middle spinal facet joint nerves using imaging guidance, each additional facet joint | 12 | $958 | $56 |
2021: 9 services
| Return visit (30+ min) | 67 | $9,884 | $114 |
| New patient visit (45+ min) | 15 | $2,157 | $144 |
| Long return visit (40+ min) | 11 | $1,749 | $159 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 16 | $1,704 | $106 |
| Short return visit (20+ min) | 18 | $1,535 | $81 |
| Telephone medical discussion with physician, 21-30 minutes | 14 | $1,460 | $86 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 13 | $799 | $61 |
| Telephone medical discussion with physician, 11-20 minutes | 11 | $696 | $58 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 12 | $650 | $46 |
Drugs they prescribed that Part D paid
$9,266
Pharmacies billed $9,266 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 13% of their Part D prescriptions (59 of 443) in 2024. At or below the middle of the specialty; the typical pain management clinician is at 44%. Long-acting opioids: 20% of their opioid prescriptions.
435 generic and fewer than 11 brand-name prescriptions · $9,266 in drug cost · 30 antibiotic prescriptions to 29 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Buprenorphine | 11 | $3,293 | $299 |
| Gabapentin | 124 | $1,627 | $13 |
| Pregabalin | 47 | $1,336 | $28 |
| Duloxetine | 33 | $543 | $16 |
| Tramadol | 31 | $211 | $7 |
See all 9 drugs
| Buprenorphine | 11 | $3,293 | $299 |
| Gabapentin | 124 | $1,627 | $13 |
| Pregabalin | 47 | $1,336 | $28 |
| Duloxetine | 33 | $543 | $16 |
| Tramadol | 31 | $211 | $7 |
| Methylprednisolone | 29 | $165 | $6 |
| Desipramine | 11 | $163 | $15 |
| Cephalexin | 24 | $71 | $3 |
| Meloxicam | 34 | $70 | $2 |
Year by year
| 2024 | 443 | 164 | 13% (59) | None | $9,266 |
| 2023 | 859 | 257 | 9% (78) | None | $12,475 |
| 2022 | 775 | 217 | 17% (134) | None | $10,510 |
| 2021 | 68 | 40 | None | None | $1,433 |
| 2017 | 85 | 32 | 0% (0) | 36% | $7,203 |
| 2016 | 41 | 20 | 0% (0) | 27% | $2,472 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 13 drugs
| Gabapentin | 249 | $2,336 | $9 |
| Pregabalin | 40 | $1,927 | $48 |
| Duloxetine | 77 | $1,901 | $25 |
| Buprenorphine-Naloxone | 12 | $1,059 | $88 |
| Hydrocodone-Acetaminophen | 24 | $721 | $30 |
| Meloxicam | 142 | $687 | $5 |
| Methylprednisolone | 44 | $444 | $10 |
| Diclofenac | 30 | $432 | $14 |
| Desipramine | 13 | $319 | $25 |
| Tizanidine | 44 | $301 | $7 |
| Tramadol | 37 | $155 | $4 |
| Cyclobenzaprine | 21 | $120 | $6 |
| Cephalexin | 14 | $82 | $6 |
2022: 12 drugs
| Gabapentin | 143 | $1,327 | $9 |
| Celecoxib | 42 | $968 | $23 |
| Tizanidine | 103 | $935 | $9 |
| Hydrocodone-Acetaminophen | 46 | $885 | $19 |
| Duloxetine | 43 | $676 | $16 |
| Tramadol | 72 | $675 | $9 |
| Meloxicam | 138 | $414 | $3 |
| Pregabalin | 21 | $407 | $19 |
| Diclofenac | 22 | $375 | $17 |
| Methylprednisolone | 41 | $315 | $8 |
| Acetaminophen-Codeine | 11 | $227 | $21 |
| Amoxicillin-Clavulanate Potass | 11 | $35 | $3 |
Money from drug and device companies
$114 in 2025
| 2025 | 2 | 5 | None | $114 |
| 2024 | 4 | 15 | None | $585 |
| 2023 | 8 | 25 | None | $1,079 |
| 2022 | 8 | 48 | None | $2,335 |
| 2021 | 5 | 17 | None | $1,075 |
| 2020 | 2 | 11 | None | $4,010 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbott Laboratories | Proclaim | $91 | 4 payments
|
| Boston Scientific | Intracept | $22 | 1 payment
|
See all 5 published payments
| Abbott Laboratories | Meals · 2025-10-05 | Proclaim | $27 |
| Abbott Laboratories | Meals · 2025-09-04 | Proclaim | $24 |
| Abbott Laboratories | Meals · 2025-07-18 | Penta | $24 |
| Abbott Laboratories | Meals · 2025-03-19 | Eterna | $17 |
| Boston Scientific | Meals · 2025-02-19 | Intracept | $22 |
See earlier years (2024, 2023, 2022, 2021, 2020)
2024: $585
| Abbott Laboratories | Eterna | $224 | 5 payments
|
| Nevro | Senza | $183 | 2 payments
|
| Boston Scientific | Intracept | $129 | 6 payments
|
| SPR Therapeutics | Sprint Pns System | $48 | 2 payments
|
2023: $1,079
| SPR Therapeutics | Sprint Pns System | $333 | 3 payments
|
| Boston Scientific | Wavewriter Alpha Prime 16 | $274 | 6 payments
|
| Nevro | Senza | $180 | 4 payments
|
| Painteq | Painteq | $71 | 3 payments
|
| Abbott Laboratories | Proclaim | $64 | 3 payments
|
| Mml US | Reactiv8 | $61 | 1 payment
|
| Medtronic | Intellis Adaptivestim | $58 | 2 payments
|
| Relievant Medsystems | Intracept | $39 | 3 payments
|
2022: $2,335
| Boston Scientific | Superion Indirect Decompression System | $1,426 | 19 payments
|
| Nevro | Omnia | $529 | 13 payments
|
| Relievant Medsystems | Intracept | $106 | 6 payments
|
| Medtronic | Intellis Adaptivestim | $91 | 5 payments
|
| Abbott Laboratories | Proclaim | $71 | 1 payment
|
| SPR Therapeutics | Sprint Pns System | $49 | 2 payments
|
| Painteq | Painteq | $34 | 1 payment
|
| Si-Bone | None | $28 | 1 payment
|
2021: $1,075
| Boston Scientific | Superion | $842 | 12 payments
|
| Abbott Laboratories | Proclaim Ipg | $131 | 2 payments
|
| Relievant Medsystems | Intracept | $40 | 1 payment
|
| Allergan | Botox | $39 | 1 payment
|
| Medtronic | Intellis | $23 | 1 payment
|
2020: $4,010
| Medtronic USA | Synchromed | $3,388 | 3 payments
|
| Boston Scientific | Superion | $622 | 8 payments
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 77.6 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1891072070
- Licence
- CA A150520, CA CA 64932California A150520: Current · expires 2027-05-31
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 207LP2900X (207LP2900X); Federal specialty code 183500000X (183500000X); Federal specialty code 207L00000X (207L00000X); Student in a training program (390200000X)
- Mailing address
- 5767 W Century Blvd Ste 400, Los Angeles, CA, 90045
- NPI first listed
- 2011-11-15
- NPI last updated
- 2021-11-18
- NPI record certified
- 2021-11-18
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 19950 Rinaldi St Ste 100, Northridge, CA, 91326 · 2425 Geary Blvd, San Francisco, CA, 94115 · 3605 Alamo St Ste 200, Simi Valley, CA, 93063 · 300 Pasteur Dr Rm H3580, Stanford, CA, 94305 · 375 Rolling Oaks Dr Ste 210, Thousand Oaks, CA, 91361
This office lists an electronic records connection.